32 min listen
Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease
Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease
ratings:
Length:
24 minutes
Released:
Jul 8, 2019
Format:
Podcast episode
Description
In the first segment, Dr. Jeffrey Ratliff talks with Dr. Franziska Hopfner about her paper on the use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease. In the second part of the podcast, Dr. Jason Crowell focuses his discussion with Dr. Jerzy Szaflarski on his JAMA Neurology paper on the US Food and Drug Administration’s authorization of the first cannabis-derived pharmaceutical. You can read the paper here: https://jamanetwork.com/journals/jamaneurology/article-abstract/2714720.
Released:
Jul 8, 2019
Format:
Podcast episode
Titles in the series (100)
September 25 2007 Issue: Outcome in Low-Grade Glioma: The Impact of Prognostic Factors and Treatment by Neurology® Podcast